EU
Emory University Portfolio holdings
AUM
$27.7M
This Quarter Return
-14.41%
1 Year Return
+31.53%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$127M
AUM Growth
+$127M
(-17%)
Cap. Flow
-$2.57M
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
51.19%
Holding
54
New
8
Increased
17
Reduced
15
Closed
8
Top Buys
| 1 |
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
|
$2.71M |
| 2 |
Crinetics Pharmaceuticals
CRNX
|
$2.58M |
| 3 |
BioCryst Pharmaceuticals
BCRX
|
$2.56M |
| 4 |
Rhythm Pharmaceuticals
RYTM
|
$2.23M |
| 5 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$1.98M |
Top Sells
| 1 |
DBVT
DBV Technologies
DBVT
|
$3.11M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$2.96M |
| 3 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
$2.64M |
| 4 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$2.58M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
$2.54M |
Sector Composition
| 1 | Healthcare | 48.32% |
| 2 | Financials | 34.37% |
| 3 | Consumer Discretionary | 6.74% |
| 4 | Industrials | 2.63% |
| 5 | Real Estate | 1.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Berkshire Hathaway Class A
BRK.A
$1.09T
| $35.8M | 28.21% | 117 | – | – |
|
2
JD.com
JD
$44.1B
| $8.32M | 6.56% | 397,578 | – | – |
|
3
InflaRx
IFRX
$108M
| $2.96M | 2.33% | 81,436 -9,001 | -10% | -$327K |
|
|
RARX
4
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $2.71M | 2.14% | +149,108 | New | +$2.71M |
|
|
5
Crinetics Pharmaceuticals
CRNX
$2.92B
| $2.58M | 2.03% | +85,944 | New | +$2.58M |
|
|
GBT
6
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $2.57M | 2.03% | 62,643 +8,692 | +16% | +$357K |
|
|
7
BioCryst Pharmaceuticals
BCRX
$1.74B
| $2.56M | 2.02% | +317,745 | New | +$2.56M |
|
|
ONC
8
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $2.55M | 2.01% | 18,168 +1,526 | +9% | +$214K |
|
9
Ascendis Pharma
ASND
$11.8B
| $2.46M | 1.94% | 39,217 +731 | +2% | +$45.8K |
|
10
Wave Life Sciences
WVE
$1.53B
| $2.45M | 1.93% | 58,227 +1,824 | +3% | +$76.7K |
|
|
SGEN
11
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.35M | 1.85% | 41,539 +5,705 | +16% | +$323K |
|
12
Alnylam Pharmaceuticals
ALNY
$58.5B
| $2.33M | 1.84% | 31,959 +4,275 | +15% | +$312K |
|
13
Incyte
INCY
$16.5B
| $2.27M | 1.79% | 35,671 -2,966 | -8% | -$189K |
|
|
14
Rhythm Pharmaceuticals
RYTM
$6.85B
| $2.23M | 1.75% | +82,767 | New | +$2.23M |
|
15
Iovance Biotherapeutics
IOVA
$807M
| $2.19M | 1.73% | 247,642 +61,727 | +33% | +$546K |
|
16
Heron Therapeutics
HRTX
$207M
| $2.19M | 1.72% | 84,265 +14,425 | +21% | +$374K |
|
|
ZGNX
17
DELISTED
Zogenix, Inc.
ZGNX
| $2.11M | 1.66% | 57,822 +448 | +0.8% | +$16.3K |
|
18
Travere Therapeutics
TVTX
$1.56B
| $2.1M | 1.66% | 92,940 -4,570 | -5% | -$103K |
|
19
Amicus Therapeutics
FOLD
$2.34B
| $2.09M | 1.64% | 217,874 +15,148 | +7% | +$145K |
|
20
BioMarin Pharmaceuticals
BMRN
$11.2B
| $2.07M | 1.63% | 24,302 -2,638 | -10% | -$225K |
|
|
MYOV
21
DELISTED
Myovant Sciences Ltd.
MYOV
| $2.04M | 1.61% | 124,151 -2,649 | -2% | -$43.5K |
|
22
Acadia Pharmaceuticals
ACAD
$4.38B
| $1.98M | 1.56% | 122,615 -73,986 | -38% | -$1.2M |
|
|
XLRN
23
DELISTED
Acceleron Pharma Inc.
XLRN
| $1.98M | 1.56% | +45,445 | New | +$1.98M |
|
|
GHDX
24
DELISTED
Genomic Health, Inc.
GHDX
| $1.95M | 1.54% | 30,319 -17,484 | -37% | -$1.13M |
|
25
Madrigal Pharmaceuticals
MDGL
$9.76B
| $1.92M | 1.51% | 17,038 +5,647 | +50% | +$637K |
|